Atossa Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Seattle, WA
ATOS chart
What traders are saying about $ATOS
Latest postsAtossa Therapeutics, Inc. news
- Atossa Therapeutics, Inc. Estimates – NASDAQ:ATOS
TradingView ·
- Atossa Therapeutics Common Stock to Begin Trading with Stapled Contingent Value Rights After Close of Business Today
Yahoo Finance ·
- Atossa Therapeutics Executes Contingent Value Rights Agreement Providing Shareholders Participation in Potential Priority Review Voucher Value
Yahoo Finance ·
- Atossa plans shareholder stake in potential PRV proceeds
pharmaceutical-technology.com ·
- Atossa Therapeutics Announces Plan to Issue Stapled CVR for Shareholders Tied to Potential Rare Pediatric Disease Priority Review Voucher
Yahoo Finance ·
- Atossa Therapeutics CEO Dr. Steven Quay to Participate in ARDD 2026 Panel on Clinical Trials and Regulatory Pathways for Diseases of Aging
Yahoo Finance ·
- ATOS: Multiple Catalysts Converge in 2H26
Yahoo Finance ·
- Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update
Yahoo Finance ·
- Atossa Therapeutics Announces Publication of Novel (Z)-Endoxifen-Related Compounds Demonstrating Potent Anti-Cancer Activity in ER-Positive Breast Cancer
Yahoo Finance ·
- Straight Out Of A Soap Opera: Biotech Exec Arrested After 21 Years On The Run
Yahoo Finance ·
- Atossa Therapeutics Announces Presentation of Mechanism-Driven (Z)-Endoxifen Data in McCune-Albright Syndrome at AACR Special Conference on Rare Cancers
Yahoo Finance ·
- ATOS: Raises up to $16.5 Million in Registered Direct Offering
Yahoo Finance ·
Atossa Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Net income | -$34.8M | -$25.5M | -$30.1M | -$27.0M |
| Diluted EPS | $-4.04 | $-3.04 | $-0.24 | $-0.21 |
| Total assets (year end) | $47.6M | $76.4M | $96.3M | $123.5M |
| Cash and equivalents (year end) | $41.3M | $71.1M | $88.5M | $110.9M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Atossa Therapeutics, Inc.
- Ticker
- ATOS (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Seattle, WA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1488039
- Former names
- ATOSSA GENETICS INC
Frequently asked questions
What exchange is Atossa Therapeutics, Inc. listed on?
Atossa Therapeutics, Inc. trades on the Nasdaq under the ticker symbol ATOS.
What industry is Atossa Therapeutics, Inc. in?
Atossa Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Atossa Therapeutics, Inc. headquartered?
Atossa Therapeutics, Inc.'s business address on file with the SEC is in Seattle, WA.
When does Atossa Therapeutics, Inc.'s fiscal year end?
Atossa Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Atossa Therapeutics, Inc. report?
Atossa Therapeutics, Inc. reported $1,758 in revenue for calendar year 2015, according to its SEC filings.